These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 22888209

  • 1. Loteprednol etabonate gel 0.5% for postoperative pain and inflammation after cataract surgery: results of a multicenter trial.
    Fong R, Leitritz M, Siou-Mermet R, Erb T.
    Clin Ophthalmol; 2012; 6():1113-24. PubMed ID: 22888209
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% for the treatment of inflammation and pain following cataract surgery.
    Comstock TL, Paterno MR, Singh A, Erb T, Davis E.
    Clin Ophthalmol; 2011; 5():177-86. PubMed ID: 21383946
    [Abstract] [Full Text] [Related]

  • 3. Loteprednol etabonate ophthalmic gel 0.5% following cataract surgery: integrated analysis of two clinical studies.
    Rajpal RK, Fong R, Comstock TL.
    Adv Ther; 2013 Oct; 30(10):907-23. PubMed ID: 24136301
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of loteprednol etabonate 0.5% gel in the treatment of ocular inflammation and pain after cataract surgery.
    Rajpal RK, Roel L, Siou-Mermet R, Erb T.
    J Cataract Refract Surg; 2013 Feb; 39(2):158-67. PubMed ID: 23218817
    [Abstract] [Full Text] [Related]

  • 5. Submicron loteprednol etabonate ophthalmic gel 0.38% for the treatment of inflammation and pain after cataract surgery.
    Fong R, Silverstein BE, Peace JH, Williams JI, Vittitow JL.
    J Cataract Refract Surg; 2018 Oct; 44(10):1220-1229. PubMed ID: 30193927
    [Abstract] [Full Text] [Related]

  • 6. Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies.
    Fong R, Cavet ME, DeCory HH, Vittitow JL.
    Clin Ophthalmol; 2019 Oct; 13():1427-1438. PubMed ID: 31447544
    [Abstract] [Full Text] [Related]

  • 7. A double-masked, placebo-controlled evaluation of 0.5% loteprednol etabonate in the treatment of postoperative inflammation. The Loteprednol Etabonate Postoperative Inflammation Study Group 2.
    Ophthalmology; 1998 Sep; 105(9):1780-6. PubMed ID: 9754192
    [Abstract] [Full Text] [Related]

  • 8. Loteprednol etabonate gel 0.5% vs prednisolone acetate suspension 1% for the treatment of inflammation after cataract surgery in children.
    Vittitow JL, Williams JI.
    J Cataract Refract Surg; 2020 Aug; 46(8):1092-1101. PubMed ID: 32352250
    [Abstract] [Full Text] [Related]

  • 9. Safety and tolerability of loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension in pediatric subjects.
    Comstock TL, Paterno MR, Bateman KM, Decory HH, Gearinger M.
    Paediatr Drugs; 2012 Apr 01; 14(2):119-30. PubMed ID: 22292487
    [Abstract] [Full Text] [Related]

  • 10. Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%: A Review in Post-Operative Inflammation and Pain Following Ocular Surgery.
    Kang C, Keam SJ, Shirley M, Syed YY.
    Clin Drug Investig; 2020 Apr 01; 40(4):387-394. PubMed ID: 32172521
    [Abstract] [Full Text] [Related]

  • 11. Double-masked, placebo-controlled evaluation of loteprednol etabonate 0.5% for postoperative inflammation. Loteprednol Etabonate Post-operative Inflammation Study Group 1.
    Stewart R, Horwitz B, Howes J, Novack GD, Hart K.
    J Cataract Refract Surg; 1998 Nov 01; 24(11):1480-9. PubMed ID: 9818338
    [Abstract] [Full Text] [Related]

  • 12. Loteprednol etabonate ophthalmic gel 0.5%: a review of its use in post-operative inflammation and pain following ocular surgery.
    Lyseng-Williamson KA.
    Drugs; 2013 Jun 01; 73(9):949-58. PubMed ID: 23740411
    [Abstract] [Full Text] [Related]

  • 13. Loteprednol etabonate suspension 0.2% administered QID compared with olopatadine solution 0.1% administered BID in the treatment of seasonal allergic conjunctivitis: a multicenter, randomized, investigator-masked, parallel group study in Chinese patients.
    Gong L, Sun X, Qu J, Wang L, Zhang M, Zhang H, Wang L, Gu Y, Elion-Mboussa A, Roy L, Zhu B.
    Clin Ther; 2012 Jun 01; 34(6):1259-1272.e1. PubMed ID: 22627057
    [Abstract] [Full Text] [Related]

  • 14. Real world use of loteprednol etabonate ophthalmic gel 0.5% in cases representative of comorbid pathologies responding to minimally invasive glaucoma surgery.
    Sheppard JD, Singh IP.
    Clin Ophthalmol; 2019 Jun 01; 13():1279-1288. PubMed ID: 31409967
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of twice daily administration of KPI-121 1% for ocular inflammation and pain following cataract surgery.
    Kim T, Sall K, Holland EJ, Brazzell RK, Coultas S, Gupta PK.
    Clin Ophthalmol; 2019 Jun 01; 13():69-86. PubMed ID: 30643381
    [Abstract] [Full Text] [Related]

  • 16. Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery.
    Lane SS, Holland EJ.
    J Cataract Refract Surg; 2013 Feb 01; 39(2):168-73. PubMed ID: 23232255
    [Abstract] [Full Text] [Related]

  • 17. A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis.
    Chen M, Gong L, Sun X, Gu Y, He X, Qu J, Wang L, Zhang M, Zhong X.
    Curr Med Res Opin; 2012 Mar 01; 28(3):385-94. PubMed ID: 22256909
    [Abstract] [Full Text] [Related]

  • 18. A retrospective analysis of the postoperative use of loteprednol etabonate gel 0.5% following laser-assisted in situ keratomileusis or photorefractive keratectomy surgery.
    Salinger CL, Gordon M, Jackson MA, Perl T, Donnenfeld E.
    Clin Ophthalmol; 2015 Mar 01; 9():2089-97. PubMed ID: 26609219
    [Abstract] [Full Text] [Related]

  • 19. Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure.
    Sheppard JD, Comstock TL, Cavet ME.
    Adv Ther; 2016 Apr 01; 33(4):532-52. PubMed ID: 26984315
    [Abstract] [Full Text] [Related]

  • 20. Comparison of Efficacy of Difluprednate 0.05% and Loteprednol Gel 0.5% After Cataract Surgery.
    Abessi B, Brooksby L, Schultze RL.
    Eye Contact Lens; 2018 Nov 01; 44 Suppl 2():S37-S42. PubMed ID: 28628490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.